Ghana becomes first country to approve Oxford’s malaria vaccine

For years, scientists have been trying to develop vaccines for the disease which kills more than 600,000 people annually – most of them in Africa.

Ghana has become the first country in the world to approve a new malaria vaccine from Oxford University, with children under the age of three in line to benefit, although it is unclear when the rollout will begin.

The mosquito-borne disease kills more than 600,000 people each year, most of them children in Africa, and scientists have been trying for years to develop vaccines.